Company page
Synmosa Biopharma Corp
Synmosa Biopharma Corp, trading under the ticker 4114, is a public company listed on the Taiwan market. The company has a market capitalization of approximately NT$484.96 million. Synmosa focuses on biopharmaceutical development and aims to enhance healthcare solutions.
- Ticker
- 4114:TPEX
- Asset type
- Stock
- Market cap
- $485.0M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- TPEX
- Currency
- TWD